Recent research conducted by Mount Sinai has unveiled concerning evidence regarding the presence of PFAS, commonly known as “forever chemicals,” in umbilical cord blood. Testing 120 samples, the study discovered 42 different PFAS compounds, far exceeding previous estimates. This finding raises significant concerns about the exposure fetuses face during a critical developmental phase.
Extensive Research Uncovers Hidden Compounds
Historically, testing for PFAS in umbilical cord blood has focused primarily on a limited selection of compounds, such as PFOA and PFOS. However, the new study employed an advanced “non-targeted analysis” methodology that expands the scope of detectable substances. By examining samples that had previously identified only four PFAS types, researchers were able to uncover a much broader range of 42 different compounds.
Shelley Liu, an associate professor at the Icahn School of Medicine and co-author of the study, explained the significance of these findings. “Babies are exposed to many more PFAS than we previously thought,” she noted, emphasising the vulnerability of fetuses during this crucial period of development.
The Health Risks of PFAS Compounds
PFAS encompass a vast class of approximately 15,000 synthetic chemicals that are predominantly used to create products with water-, stain-, and grease-resistant properties. Their persistence in the environment has earned them the moniker “forever chemicals,” as they do not break down naturally. Research has associated these compounds with a range of severe health issues, including cancer, birth defects, compromised immunity, elevated cholesterol levels, and kidney disease.
The implications of fetal exposure to PFAS are especially troubling. A comprehensive review of 40 studies revealed that researchers detected PFAS in 30,000 umbilical cord blood samples. Notably, elevated PFAS levels in mothers correlate with an increased risk of infant mortality, low birth weight, and future obesity. Moreover, studies suggest links between fetal exposure to these chemicals and later-life health complications such as cancer, neurological disorders, and cardiovascular diseases.
Regulatory Gaps and the Need for Comprehensive Testing
The compounds that have historically been monitored, such as PFOA and PFOS, have largely been phased out in favour of newer PFAS alternatives, which manufacturers often claim are less toxic. However, there is growing concern that these newer compounds may also pose risks, as they can break down into different substances once in the environment or within the human body.
Current regulatory methods, particularly those employed by the US Environmental Protection Agency (EPA), have not kept pace with the evolving landscape of PFAS. The EPA typically tests water samples for around 30 to 40 compounds, despite independent research indicating the presence of thousands. A 2022 analysis highlighted how regulatory bodies frequently underestimate PFAS levels in water.
The Mount Sinai study effectively juxtaposed traditional testing methods with the broader non-targeted analysis, illustrating a clear disparity in findings. While the EPA has recently certified a blood test that identifies 53 compounds, the Mount Sinai research revealed 31 additional PFAS types not included in this assessment.
Implications for Infant Health
While the Mount Sinai study did not directly investigate the health ramifications of these elevated PFAS levels, Liu remarked that the potential consequences remain uncertain. Generally, increased PFAS concentrations in blood are associated with heightened health risks.
The blood samples analysed were drawn as part of the federal government’s Home Study, which investigates PFAS exposure and its long-term health outcomes. The authors of the study intend to further explore the health implications of their findings.
David Andrews, acting chief science officer at the Environmental Working Group, underscored the significance of this research. “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS,” he stated.
Why it Matters
The findings from this study underscore a pressing public health concern and highlight the urgent need for enhanced regulatory measures. The widespread presence of PFAS in umbilical cord blood not only poses potential health risks to newborns but also reflects broader environmental and health policy deficiencies. As awareness of these “forever chemicals” grows, proactive steps must be taken to mitigate exposure and safeguard future generations from the long-term consequences of these persistent pollutants.
